Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105037277B reveals xylonic acid catalysis for high-yield heterocyclic synthesis offering supply chain stability.
Patent CN102277322A details a green enzymatic route for IDA production, offering lower costs and reduced waste compared to traditional chemical hydrolysis methods.
Patent CN102277322A details a novel enzymatic route for Iminodiacetic Acid (IDA) synthesis, offering significant waste reduction and milder reaction conditions compared to traditional chemical hydrolysis methods.
Patent CN104910188A reveals a one-pot synthetic method for cefazolin acid, offering high yield, reduced solvent use, and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN115888844A reveals a breakthrough Hiyama coupling method for p-vinylbenzoic acid, offering superior yield and scalability for reliable industrial supply chains.
Novel synthesis method for quinoline-2-boronic acid pinacol ester offering high purity and scalable industrial production for pharmaceutical intermediates.
Discover a cost-effective, safe process for synthesizing N-substituted piperidine-4-boronic acid intermediates, eliminating expensive palladium catalysts.
Novel chiral Lewis acid process for high-purity diltiazem intermediates. Reduces steps and eliminates expensive reagents for scalable pharmaceutical manufacturing.
Novel 7-ACA silanization method improves yield and purity significantly. Reduces sewage and drying time for pharmaceutical intermediates manufacturing processes effectively.
Patent CN101979393B details a novel silylation route for cephalothin acid offering high purity and reduced environmental impact for pharmaceutical supply chains.
Patent CN104673733B reveals a novel HHDH enzyme route for high-purity statin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Advanced synthesis of 3-dehydroshikimic esters via IBX oxidation. A scalable, high-yield route for pharmaceutical intermediates offering significant cost and supply chain advantages.
Patent CN106316825A reveals a scalable chemical route for trans-4-hydroxycyclohexanecarboxylic acid. This method offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN102558098A reveals a cost-effective one-pot synthesis for EGFR inhibitor intermediates, offering significant supply chain advantages for API manufacturers.
Patent CN102558098A details a one-pot synthesis for EGFR inhibitor intermediates, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Novel one-pot method replaces Pd catalysis for EGFR inhibitor intermediates, offering cost-effective scale-up and high purity for pharma supply chains.
Patent CN101434609B details a tungstate-catalyzed oxidation of 6-APA. This green process offers high yield and safety for reliable pharmaceutical intermediate supply chains.
Patent CN105254611A reveals a waste-utilization route for benzothiophene-2-carboxylic acid. This method offers significant supply chain stability and cost advantages.
Patent CN104651292A reveals high-purity S-CHBE synthesis via recombinant E. coli. Achieves 100% conversion and 99.4% ee for scalable pharmaceutical intermediates.
Patent CN103290078B reveals purified enzyme catalysis for 5-aminovaleric acid production offering simplified separation and high yield for scalable polymer intermediate manufacturing supply chains.